• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Janssen Inc. - Articles and news items

rheumatoid-arthritis

Janssen submits EU application for rheumatoid arthritis drug

Industry news / 16 September 2016 / Niamh Louise Marriott, Digital Content Producer

Sirukumab is a human monoclonal IgG1 kappa antibody that targets the cytokine IL-6, a protein believed to play a role in autoimmune rheumatoid arthritis…

esketamine depression drug

FDA grants breakthrough therapy designation for depression drug

Industry news / 16 August 2016 / Janssen

Following succesful phase II trials, the FDA have granted a Breakthrough Therapy Designation for esketamine, an investigational antidepressant medication…

Sirukumab

Sirukumab meets both co-primary endpoints in rheumatoid arthritis study

Industry news / 8 June 2016 / Victoria White, Digital Content Producer

The SIRROUND-D study met both co-primary endpoints in evaluating treatment with sirukumab in adult patients with active rheumatoid arthritis…

ibrutinib

NICE asks Janssen to put ibrutinib forward for the CDF

Industry news / 1 June 2016 / Victoria White, Digital Content Producer

NICE has asked Janssen to set out a case for including its chronic lymphocytic leukaemia (CLL) drug ibrutinib (Imbruvica) in the Cancer Drugs Fund (CDF)…

crohn's disease

Clinical remission data for Stelara in Crohn’s disease presented at DDW

Industry news / 25 May 2016 / Victoria White, Digital Content Producer

Data shows that a greater proportion of adult patients with Crohn’s disease receiving Stelara SC maintenance therapy were in clinical remission at one year…

type 2 diabetes

NICE recommends three type 2 diabetes treatments

Industry news / 25 May 2016 / Victoria White, Digital Content Producer

NICE has published final guidance recommending three drugs for treating type 2 diabetes: canagliflozin, dapagliflozin and empagliflozin…

Daratumumab

Daratumumab combination improves PFS in multiple myeloma study

Industry news / 1 April 2016 / Victoria White

Daratumumab combination treatment regimen improved progression-free survival compared with bortezomib and dexamethasone alone…

Daratumumab

Daratumumab and atezolizumab to be evaluated in two studies

Industry news / 22 March 2016 / Victoria White

The studies will assess the combination of daratumumab and atezolizumab in multiple myeloma and in solid tumour cancer…

abiraterone

NICE recommends abiraterone for some prostate cancer patients

Industry news / 21 March 2016 / Victoria White

Professor Paul Workman of The Institute of Cancer Research, which discovered abiraterone, said the recommendation was “a big victory for men”…

HM12525A

Hanmi and Janssen sign agreement to develop HM12525A

Industry news / 11 November 2015 / Victoria White

HM12525A is a novel biologic GLP-1/Glucagon dual receptor agonist to treat diabetes and obesity…

spine-Simponi

CHMP adopts positive opinion of Simponi for the treatment of non-radiographic axial spondyloarthritis

Industry news / 26 May 2015 / Victoria White

CHMP has adopted a positive opinion of Simponi for the treatment of adults with severe active non-radiographic axial spondyloarthritis…

Prince Charles (Marc Burleigh / Shutterstock.com)

The Prince of Wales marks the 10th anniversary of International Health Partners as they launch EURMED

Industry news / 9 December 2014 / Janssen

International Health Partners (IHP) in partnership with Banco Farmaceutico and Action Medeor has launched EURMED; a unique industry collaboration that enables the donation of medicines for disaster relief and humanitarian aid.

 

Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +